Journal
CURRENT OPINION IN PHARMACOLOGY
Volume 2, Issue 1, Pages 23-33Publisher
ELSEVIER SCI LTD
DOI: 10.1016/S1471-4892(01)00117-5
Keywords
-
Categories
Ask authors/readers for more resources
Corticotropin-releasing factor (CRF) and its related family members are implicated in stress-related disorders such as anxiety and depression. Recently, two new members of this neuropeptide family have been discovered in the brain: urocortin 11 (also known as stresscopin-related peptide) and urocortin III (also known as stresscopin). These urocortins are selective agonists for the CRF2 receptor, show a distinct neuroanatomical localization and are involved in stress-coping responses such as anxiolysis. Thus, CRF the urocortins and their receptors form an intricate network in the brain involved in the acute phase as well as the recovery phase of the stress response.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available